Read Anywhere and on Any Device!

Subscribe to Read | $0.00

Join today and start reading your favorite books for Free!

Create Free Account

Quick and Easy Sign Up!

It takes less then 1 minute to sign up, then you can enjoy Unlimited eBooks.

Sign Up Browse

Popular Genres

Read Anywhere and on Any Device!

  • Download on iOS
  • Download on Android
  • Download on iOS

Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A practical resource for nurses

Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A practical resource for nurses

R.J. Buka
0/5 ( ratings)
Read Download
Diffuse large B-cell lymphoma is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine. Table of • an overview • CAR T cells • CAR T-cell products • Delivering CAR T-cell therapy and managing patient expectations • CAR T-cell therapy-related toxicities
Language
English
Format
Kindle Edition
Release
September 30, 2021

Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A practical resource for nurses

R.J. Buka
0/5 ( ratings)
Read Download
Diffuse large B-cell lymphoma is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine. Table of • an overview • CAR T cells • CAR T-cell products • Delivering CAR T-cell therapy and managing patient expectations • CAR T-cell therapy-related toxicities
Language
English
Format
Kindle Edition
Release
September 30, 2021

More books from R.J. Buka

Fast Facts: CAR T-Cell Therapy: Insight into current and future applications

0/5 ( ratings)

Rate this book!

Write a review?

loader